A noncontrolled trial of anti-TNF-α chimeric monoclonal antibody (infliximab, Remicade®) in exudative age-related macular degeneration

Additional Metadata
Persistent URL	doi.org/10.1111/aos.12471, hdl.handle.net/1765/52162
Journal	Acta Ophthalmologica (Print)
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	van Hagen, M., Baarsma, S., van Bilsen, C., Kuijpers, R., van Laar, J., van der Ent, M., … Missotten, T. (2014). A noncontrolled trial of anti-TNF-α chimeric monoclonal antibody (infliximab, Remicade®) in exudative age-related macular degeneration. Acta Ophthalmologica (Print). doi:10.1111/aos.12471

Publication